Therapeutic compounds and compositions
The present invention provides compounds and compositions that inhibit Factor Xla or kallikrein and methods of using these compounds and composition.
Saved in:
| Main Authors | , , , , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
27.05.2021
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides compounds and compositions that inhibit Factor Xla or kallikrein and methods of using these compounds and composition. |
|---|---|
| AbstractList | The present invention provides compounds and compositions that inhibit Factor Xla or kallikrein and methods of using these compounds and composition. |
| Author | CHRUSCIEL, Robert A NAVIA, Manuel HAYWARD, Neil J STASSEN, Frans L STEWART, Catherine A MELNICK, Michael J GADWOOD, Robert C POEL, Toni J |
| Author_xml | – fullname: STEWART, Catherine A – fullname: MELNICK, Michael J – fullname: NAVIA, Manuel – fullname: STASSEN, Frans L – fullname: GADWOOD, Robert C – fullname: HAYWARD, Neil J – fullname: POEL, Toni J – fullname: CHRUSCIEL, Robert A |
| BookMark | eNrjYmDJy89L5WRQC8lILUosSC0tyUxWSM7PLcgvzUspVkjMS4HwijNLMvPzinkYWNMSc4pTeaE0N4OKm2uIs4duakF-fGpxQWJyal5qSbxjqJGBoaWRhbGFuZmTk5ExkcoAjgArUQ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | AU2019283876BB2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_AU2019283876BB23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Sep 20 10:07:34 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_AU2019283876BB23 |
| Notes | Application Number: AU20190283876 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210527&DB=EPODOC&CC=AU&NR=2019283876B2 |
| ParticipantIDs | epo_espacenet_AU2019283876BB2 |
| PublicationCentury | 2000 |
| PublicationDate | 20210527 |
| PublicationDateYYYYMMDD | 2021-05-27 |
| PublicationDate_xml | – month: 05 year: 2021 text: 20210527 day: 27 |
| PublicationDecade | 2020 |
| PublicationYear | 2021 |
| RelatedCompanies | EXITHERA PHARMACEUTICALS INC |
| RelatedCompanies_xml | – name: EXITHERA PHARMACEUTICALS INC |
| Score | 3.3393726 |
| Snippet | The present invention provides compounds and compositions that inhibit Factor Xla or kallikrein and methods of using these compounds and composition. |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Therapeutic compounds and compositions |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210527&DB=EPODOC&locale=&CC=AU&NR=2019283876B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTRONjU3TjHVTUxLNgJ2UEzNdC3TklJ1LVJS09LSTC1AZ0CBVlv4mXmEmnhFmEYwMeTA9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGNh_MTUyV3NxsnUN8Hfxd1Zzdgb2JNX8gkBDgZbAmhSY952ABTYrsCFtDloA5hrmBNqXUoBcqbgJMrAFAM3LKxFiYErNE2bgdIbdvSbMwOELnfIGMqG5r1iEQS0EsVlKAbQWHHQlUrFCYl4KhAddfiXKoOLmGuLsoQu0MB7uv3jHUCTXORkZizGwALv-qRIMCokWxsbGJsnmqebgCbZES2MzsxTQ1JeReWpKmqGBJIMsXqOkCMhLM3CBAg00G25kLsPAUlJUmioLrGRLkuTAYQMArlp_Eg |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LS8NAEB5KFetNq-KrmkPJLWiz3WxyKGJeRG3TIqn0FtJkFwSJxUT8-86uqe1Jb_uAfQzMzH47L4D-gOSUkYIamchNBCjUMhyx5IZdcCEEtWUOKOltEVvRfPi4oIsWvK1jYVSe0C-VHBE5Kkd-r5W8Xm0-sXzlW1ndLF9x6P0uTEa-3qBjxC_UZLrvjoLZ1J96uuchktTjZ_kV6KAmRd53UWDv4CPblpn2gxdXxqWstpVKeAC7M1yvrA-hxcsudLx17bUu7E0akzc2G-6rjkBPNsFSmvQFlyWRKi0ri59e4351DP0wSLzIwA3T3_ul9_Ot07kmOYE2Qn9-ClpmE0KGOeNMGdgyh1hWIU1fJuOFGNyeQe_Ppc7_mb-GTpRMxun4IX66gH1JQGkZN9kltOuPT95DhVsvrxSdvgHLZoIC |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Therapeutic+compounds+and+compositions&rft.inventor=STEWART%2C+Catherine+A&rft.inventor=MELNICK%2C+Michael+J&rft.inventor=NAVIA%2C+Manuel&rft.inventor=STASSEN%2C+Frans+L&rft.inventor=GADWOOD%2C+Robert+C&rft.inventor=HAYWARD%2C+Neil+J&rft.inventor=POEL%2C+Toni+J&rft.inventor=CHRUSCIEL%2C+Robert+A&rft.date=2021-05-27&rft.externalDBID=B2&rft.externalDocID=AU2019283876BB2 |